Profit & Loss

FEM CARE PHARMA LTD.

NSE : NABSE : 524608ISIN CODE : INE954D01014Industry : Household & Personal ProductsHouse : Sunil H Pophale
BSE980.050 (0 %)
PREV CLOSE ( ) 980.05
OPEN PRICE ( ) 1010.00
BID PRICE (QTY) 980.05 (201)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 389
TODAY'S LOW / HIGH ( )980.05 1010.00
52 WK LOW / HIGH ( ) 980.051010
NSE
This Company is not listed in NSE
Select year
( in Million)
Particulars
Mar 2009
Mar 2008
Mar 2007
Mar 2006
Mar 2005
INCOME :
  
  
  
  
  
Gross Sales
1085.23
946.07
822.93
745.18
643.66
     Sales
1076.18
938.25
819.58
744.99
643.36
     Job Work/ Contract Receipts
     Processing Charges / Service Income
9.06
7.82
3.35
0.20
0.30
     Revenue from property development
     Other Operational Income
0.00
0.00
0.00
0.00
0.00
Less: Excise Duty
10.53
7.86
11.55
43.35
39.12
Net Sales
1074.71
938.21
811.39
701.83
604.55
EXPENDITURE :
Increase/Decrease in Stock
-14.22
34.63
-54.25
-13.22
3.70
Raw Material Consumed
401.64
290.46
343.56
287.13
267.98
     Opening Raw Materials
44.12
45.31
18.17
9.19
11.32
     Purchases Raw Materials
262.42
175.43
237.57
90.77
87.41
     Closing Raw Materials
38.53
44.12
45.31
18.17
9.19
     Other Direct Purchases / Brought in cost
133.63
113.84
133.12
205.34
178.46
     Other raw material cost
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
9.87
6.45
5.73
2.18
2.26
     Electricity & Power
9.87
6.45
5.73
2.18
2.26
     Oil, Fuel & Natural gas
0.00
0.00
0.00
0.00
0.00
     Coals etc
0.00
0.00
0.00
0.00
0.00
     Other power & fuel
0.00
0.00
0.00
0.00
0.00
Employee Cost
123.54
116.90
84.89
68.47
58.80
     Salaries, Wages & Bonus
94.63
82.63
69.89
53.16
47.20
     Contributions to EPF & Pension Funds
7.10
7.64
5.82
5.10
4.20
     Workmen and Staff Welfare Expenses
2.96
2.14
2.51
1.29
0.79
     Other Employees Cost
18.84
24.49
6.68
8.92
6.60
Other Manufacturing Expenses
70.43
51.73
30.99
24.97
15.79
     Sub-contracted / Out sourced services
     Processing Charges
9.62
     Repairs and Maintenance
6.21
5.03
3.77
3.27
4.09
     Packing Material Consumed
15.59
11.03
14.22
4.85
4.50
     Other Mfg Exp
39.01
35.67
12.99
16.86
7.20
General and Administration Expenses
85.36
76.28
74.62
58.34
49.51
     Rent , Rates & Taxes
5.10
4.48
4.87
6.30
6.66
     Insurance
4.02
3.18
3.04
2.50
1.50
     Printing and stationery
2.93
2.97
2.25
1.80
1.82
     Professional and legal fees
13.17
14.41
15.58
8.26
7.60
     Traveling and conveyance
37.20
35.28
28.57
26.27
22.50
     Other Administration
22.93
15.96
20.31
13.22
9.42
Selling and Distribution Expenses
196.05
199.29
149.02
137.40
110.08
     Advertisement & Sales Promotion
180.10
186.48
116.73
115.54
87.83
     Sales Commissions & Incentives
15.95
12.81
6.12
7.25
5.68
     Freight and Forwarding
     Handling and Clearing Charges
0.00
0.00
0.00
0.00
0.00
     Other Selling Expenses
0.00
0.00
26.17
14.61
16.57
Miscellaneous Expenses
41.96
24.85
14.84
21.28
7.88
     Bad debts /advances written off
0.06
0.29
0.00
0.18
     Provision for doubtful debts
2.85
1.80
5.48
0.00
     Losson disposal of fixed assets(net)
0.82
0.90
0.17
0.23
     Losson foreign exchange fluctuations
6.57
0.07
     Losson sale of non-trade current investments
0.99
0.00
0.00
0.21
     Other Miscellaneous Expenses
32.47
23.05
11.85
15.63
7.19
Less: Expenses Capitalised
Total Expenditure
914.61
800.58
649.40
586.57
515.99
Operating Profit (Excl OI)
160.10
137.63
161.99
115.27
88.55
Other Income
18.05
10.25
14.03
11.58
7.83
     Interest Received
5.31
3.81
0.50
0.40
0.38
     Dividend Received
0.90
1.72
2.20
2.39
0.79
     Profit on sale of Fixed Assets
1.45
     Profits on sale of Investments
0.18
0.57
0.67
0.00
     Provision Written Back
1.32
     Foreign Exchange Gains
     Others
9.06
4.54
10.77
8.13
6.66
Operating Profit
178.14
147.88
176.02
126.84
96.38
Interest
11.34
8.17
2.40
3.09
3.78
     InterestonDebenture / Bonds
     Interest on Term Loan
2.41
1.50
0.01
0.71
1.21
     Intereston Fixed deposits
0.00
0.68
     Bank Charges etc
7.04
5.51
1.74
1.87
1.22
     Other Interest
1.89
1.15
0.65
0.50
0.67
PBDT
166.80
139.71
173.62
123.76
92.59
Depreciation
25.87
18.87
17.78
7.05
6.52
Profit Before Taxation & Exceptional Items
140.93
120.84
155.84
116.71
86.07
Exceptional Income / Expenses
-16.62
-28.80
0.00
Profit Before Tax
124.31
92.04
155.84
116.71
86.07
Provision for Tax
17.09
11.86
41.66
46.56
32.35
     Current Income Tax
15.40
6.30
34.49
44.95
28.11
     Deferred Tax
0.34
1.73
5.19
0.23
4.24
     Other taxes
1.35
3.84
1.99
1.38
0.00
Profit After Tax
107.22
80.17
114.18
70.15
53.72
Extra items
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
-12.52
-8.62
-1.01
Share of Associate
-0.72
Other Consolidated Items
Consolidated Net Profit
106.51
80.17
101.65
61.52
52.71
Adjustments to PAT
-0.34
-0.46
Profit Balance B/F
152.40
101.46
48.96
3.11
-22.96
Appropriations
258.90
181.63
150.62
64.29
29.29
     General Reserves
4.60
15.74
6.11
5.94
     Proposed Equity Dividend
21.06
27.07
24.70
10.32
     Corporate dividend tax
3.58
6.35
3.46
2.41
     Other Appropriation
Equity Dividend %
70.00
70.00
60.00
51.00
Earnings Per Share
30.18
26.65
33.79
20.45
17.53
Adjusted EPS
30.18
26.65
33.79
20.45
17.53

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.